The outbreak of coronavirus disease (COVID-19) has brought the issue of localization to the forefront, which necessitated the need for localization of pharmaceu 8 August 2022
Around one in 10 medical products in circulation in low- and middle-income countries is substandard or counterfeit, according to the World Health Organization ( 4 July 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.